TigerGene

TigerGene is a private Boston-based life sciences venture capital and company-formation firm focused on early-stage platform technologies across therapeutics, diagnostics, genomics, proteomics, synthetic biology, and related healthcare areas. The firm was co-founded by John Boyce and Audrey Warner and has been described as being seeded by Tiger Management. Rather than operating as a drug-development company with its own clinical pipeline, TigerGene forms and funds new companies around academic and scientific innovations and works closely with founders to commercialize them. Public references indicate that TigerGene later evolved or rebranded into 28 Capital, which positions itself as building on Tiger Gene's prior track record in biotech company creation and investing.